21 CFR Part 11, Electronic Signatures, & OpenClinica

Organizations that seek to submit their clinical trial results to the FDA must comply with 21 CFR Part 11: a key set of United States government regulations governing the use of electronic systems in clinical trials. Despite the fact that the government has issued guidance to try and clarify interpretation of these regulations, many people [...]